Tag: eosinophilic
Sanofi: the only drug Dupixent for the treatment of eosinophilic esophagitis – 01/30/2023 at 09:38
(AOF) – The European Commission (EC) has extended the marketing authorization for Dupixent (dupilumab) in the European Union (EU) for the treatment of eosinophilic esophagitis in adults and adolescents from…
Sanofi: CHMP recommends EU approval of Dupixent for treatment of eosinophilic esophagitis
By Jean-Noel Legalland Published on 12/16/2022 at 1:48 p.m. Photo credit © Sanofi Corporate …
Sanofi: FDA approves Dupixent to treat eosinophilic esophagitis
PARIS (Agefi-Dow Jones)–The pharmaceutical group Sanofi announced on Friday evening that the Food and Drug Administration (FDA), the American health authority, had authorized the use of its drug Dupixent for…
Sanofi: FDA grants priority review to Dupixent in eosinophilic esophagitis
PARIS (Agefi-Dow Jones)–The pharmaceutical group Sanofi announced on Monday that the Food and Drug Administration (FDA), the American health authority, had agreed to grant a priority review to its drug…